-
Breathalyzer Biopsy Company Gains $15M in New Funds
A company in the U.K. developing a technology for early and precise diagnosis of lung and other cancers by analyzing exhaled breath is raising $15 million in new venture capital.
-
Business Cash Flow Disasters You May Want To Avoid
I want to share with you some of the things you would do well to avoid and how you can solve some of the common cash flow dilemmas.
-
Infographic – Apple Emerges as Wearables Leader
Our friends at Statista provide us with this weekend’s infographic on wearables, a look at the leading vendors of wearable devices, based on data from a new IDC study.
-
Trial Shows Reduction in Huntington Disease Protein
First results from a clinical trial show an experimental therapy reduces production of a protein damaging nerve cells in people with Huntington disease.
-
Start-Up Developing Blood-Brain Barrier Treatments
A medical school professor in Singapore is starting a biotechnology company to discover and develop new drugs for neurological disorders based on his research with mechanisms for crossing the blood-brain barrier.
-
3-D Printing Devised for Sensors in Soft Robotics
Engineering researchers developed techniques using three-dimensional printing that enables robotic devices made with soft materials, like those in health care, to sense more properties of objects they encounter.
-
Science Of Logistics, And How It Can Improve Your Business
It’s a good idea to know everything you can about the science and the new developments in logistics so that you can improve this aspect of your business for maximum performance.
-
Biotech Sponsoring Microbiome-Cancer Research
A biotechnology enterprise is starting research collaborations with cancer labs in the U.S. and Germany to study interactions of gut microbes on responses of individuals to cancer immunotherapies.
-
Techniques Devised to Boost Gene Therapy Success
An engineering team at Washington University in St. Louis is developing mechanical and electronic processes to improve the success of inserting large, complex therapeutic molecules like DNA into cells.
-
Synthetic Bio Company Starts Up, Raises $53 Million
A start-up business that aims to apply principles of computer circuit design to biology and medicine in creating treatments for disease is raising $53 million in its first venture funding round.